Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Renate S. Hagedoorn et al.|Journal of Clinical Investigation|2019Cited by 232
Abstract A044: Mutated NPM1 as target for immunotherapy of acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Rogier M. Reijmers et al.|Cancer Immunology Research|2019Cited by 0